December 13 | 2019 2cureX presenterar framsteg i analysutveckling för IndiTreat® i immuno-onkologi vid ESMO Immuno-Oncology Congress i Genève 11-14 december 2019. Read more
December 10 | 2019 2cureX lanserar IndiTreat.com som en viktig komponent i 2cureX förberedelser för produktlanseringen av IndiTreat® 2020 Read more
December 10 | 2019 2cureX launches IndiTreat.com as an important component of 2cureX’s preparation for the product launch of IndiTreat® in 2020 Read more
November 22 | 2019 CORRECTION: 2cureX publishes interim report for the third quarter of 2019 Read more
November 22 | 2019 RÄTTELSE: 2cureX offentliggör delårsrapport för det tredje kvartalet 2019 Read more
November 6 | 2019 2cureX continues its efforts to ensure a strong IP protection for its IndiTreat test in the United States Read more
November 6 | 2019 2cureX fortsätter sitt arbete med att säkra ett starkt IP-skydd för sitt IndiTreat-test i USA Read more
October 15 | 2019 2cureX fortsätter sin IP-expansion genom säkrande av patent på sitt IndiTreat-test i Hong Kong Read more
October 15 | 2019 2cureX continues its IP expansion by securing a patent on Its IndiTreat test in Hong Kong Read more
October 8 | 2019 2cureX har ingått avtal med ett av de största privata cancersjukhusen i Norden Read more
October 8 | 2019 2cureX has made an agreement with one of the largest private cancer hospitals in the Nordic countries Read more
July 23 | 2019 2cureX announces that patients are successfully being enrolled in the IndiTreat® pancreatic cancer trial Read more